ArticleClinical and molecular hepatology2025

Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease.

Hye Won Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.